IL2 and acute respiratory distress syndrome: Bevacizumab is among drugs that can induce lung hemorrhage, while gemcitabine and immune-mediated therapies such as interleukin 2 and interferon may lead to ARDS or noncardiogenic pulmonary edema [33].